Olema has very interesting open positions for (Senior) Medical Director(s). Two programs are ongoing: a SERD/CERAN currently on Phase 3, and a KAT-6 inhibitor transitioning soon to clinic. Please see the latest corporate deck, and reach out if you have further questions on this impactful and exciting company! https://lnkd.in/e3XFG5BU
Elisabeth de Kermadec - Etaix, MD, MPH’s Post
More Relevant Posts
-
Day 4: Cost and Resource Management Continuing our exploration of critical topics in clinical trials, today's post revisits the ASPE article referenced earlier to highlight elements on Cost and Resource Management. Summary: The high financial costs associated with clinical trials, including administrative staff costs, site monitoring, and central laboratory costs, put additional pressure on training programs. Effective training must be ongoing and comprehensive to ensure all team members are prepared for their roles, which can be resource-intensive. Source: Here is the article again for your review: https://lnkd.in/gCVcHXeQ Please review the article and share your insights and experiences on managing costs and resources in clinical trials. #ClinicalTrials #ResourceManagement #ClinicalResearch #Pharma
-
-
Clinical, IVD, Med Device and Biotech Liaison working to bring great innovations to people in need.
Great discussion regarding FIH studies! #firstinhuman #medtech #medtechclinicalresearch #meddeviceresearch #medicaldevicecroservices #clinicaltrials #earlystageclinicaltrials #research #strategicdevelopment #clinicalstrategy
❓ What are the objectives and benefits of conducting 𝗳𝗶𝗿𝘀𝘁-𝗶𝗻-𝗵𝘂𝗺𝗮𝗻 𝘀𝘁𝘂𝗱𝗶𝗲𝘀? What are the key considerations and best practices for manufacturers? We have answers. 🏥 Here's the first video in our 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗖𝗥𝗢: 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗦𝗲𝗿𝗶𝗲𝘀 – 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗳𝗼𝗿 𝗙𝗶𝗿𝘀𝘁-𝗶𝗻-𝗛𝘂𝗺𝗮𝗻 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 (𝟭/𝟮). Join VP of Strategic Regulatory Affairs Sew-Wah Tay and VP of Global Regulatory Affairs Jaishankar Kutty, Ph.D. as they discuss crucial strategic considerations for first-in-human (FIH) studies. 𝗪𝗮𝘁𝗰𝗵 𝗮𝗻𝗱 𝘆𝗼𝘂 𝘄𝗶𝗹𝗹 𝗹𝗲𝗮𝗿𝗻: 📎 The objectives and benefits of conducting FIH studies 📎 Key considerations and best practices for manufacturers 📎 How to navigate early-stage challenges effectively Don't miss this strategic guidance that will help you streamline your FIH study process and make informed decisions. Watch now... and stay tuned for part two! #MedTech #CRO #ClinicalTrials #FirstInHuman #MedicalDevices #StrategyDevelopment #RQMPlus
-
🚀 Reduces literature review times from days to minutes🚀 We, at PubHive Ltd. are thrilled to announce a significant update to our Local Literature Auto-Tracker (LLAT) module, designed to revolutionize efficiency and productivity for life science companies and CROs. Our latest update introduces a range of powerful features that streamline and automate local literature searches and reviews, ensuring you can make informed decisions faster than ever before. Key Benefits of the Enhanced LLAT: 📅 Granular Search Options 🔄 Bulk Search and Review 📝 Bulk Commenting 🔍 Advanced Filtering With these updates, the LLAT reduces review times from days to minutes, empowering you to focus on what truly matters. Learn more about how PubHive's Local Literature Automation can enhance your workflow and simplify compliance: https://lnkd.in/ejUmMkK9 #LifeSciences #CRO #Pharmacovigilance #DrugSafety #Efficiency #Productivity #Innovation #LocalLiterature #Review #Automation
Local Literature Automation: Faster Reviews, Enhanced Efficiency
pubhive.com
-
Clinical Director Aspiring Medical Science Liaison | Medical Affairs | Dynamic Medical Doctor with 4 Years of Experience
Frequently a topic of conversation in Medical Affairs. Thought I would share this insightful paper. Looking forward to the update coming later this year. https://lnkd.in/eXwDkvf9
The Value and Deliverables of Medical Affairs: Affiliate Perspectives and Future Expectations
ncbi.nlm.nih.gov
-
Great post Gregory DuQuella, MD . Watch this video .. great story telling which shares the importance of listening to the people who have your safety at heart #risk #compliance #patientsafety
Medical Physician | Medical Monitor | Clinical Trial Physician | Freelance Writer | Medical Educator | Strategic Consultant
This is Hilarious! Especially if you’re like me…The Safety Guy! Sometimes in Clinical Trials / Medical Monitoring / Pharmacovigilance you have to make a tough call, like the Old Safety Guy, and say “No. We can’t do that. It’s not safe for the patient!” And sometimes we have to be like the New Safety Guy. Not just by letting people on top of buildings run amok. But by thinking out the box and finding progressive ways to make new ideas and technologies safer for the public. Knowing when to be the old or new guy is key! It’s a balance that takes wisdom, courage, and a lot of work. The Tom Cruise movie was done, and everyone loved it! But I’m sure Tom Cruise is still alive because the New Safety Guy went above and beyond to make his crazy intense dream come to life. He thought out the box, using super strength microfilament harnesses, CG disguised safety riggings, and by meticulously planning out every step. Because he knew that one wrong step could be the difference between making Tom Cruise’s dream come true, or just killing Tom Cruise and his dream. Safety Guys don’t want to kill your company’s medical device, or your new drug. They just want to make sure you don’t kill your company, it’s future, or your patients along the way! I’m Gregory DuQuella MD. And I’m your New Safety Guy! Clinical Trials Physician / Medical Monitor / Pharmacovigilance MD
-
Did you know that Swati S. was once a very successful Medical Science Liaison in Medical Affairs in Pharma? Here are some tips on how to be as efficient as possible in your travels in the Medical Affairs industry. This is just the beginning of a series of tips, follow PlansConnect, LLC for more tips! #MSL #nonclinicalcareer #careertransition #leanerbudget #pharma #careersinpharma #physicians #careergrowth #newskillls #linkedin #careerdevelopment #medicalaffairs
-
-
Looking to increase your knowledge of regulatory affairs and clinical trials? The UW Master of Science in Biomedical Regulatory Affairs might be a great option for you, ask me how?
UW Master of Science in Biomedical Regulatory Affairs graduates, Tony Yang and Manisha R., share how this program helped them gain expertise in shepherding medical products through the regulatory affairs process and form connections with industry experts. Watch the full video on YouTube: http://ms.spr.ly/6042cUAn6 Visit our website to learn more about the program: http://ms.spr.ly/6044cUAn8
